Free Trial
NASDAQ:AIMD

Ainos (AIMD) Stock Price, News & Analysis

Ainos logo
$0.47 +0.02 (+4.49%)
(As of 11/22/2024 ET)

About Ainos Stock (NASDAQ:AIMD)

Key Stats

Today's Range
$0.43
$0.48
50-Day Range
$0.43
$0.57
52-Week Range
$0.40
$4.29
Volume
27,624 shs
Average Volume
211,469 shs
Market Capitalization
$6.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Receive AIMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter.

AIMD Stock News Headlines

Ainos announces IRB approval for Sjogren’s Syndrome clinical study
I've got news for you…
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
Ainos files complaints over concerns about unsual trading activity
See More Headlines

AIMD Stock Analysis - Frequently Asked Questions

Ainos' stock was trading at $2.05 at the beginning of 2024. Since then, AIMD shares have decreased by 77.3% and is now trading at $0.4659.
View the best growth stocks for 2024 here
.

Ainos, Inc. (NASDAQ:AIMD) issued its quarterly earnings results on Wednesday, November, 6th. The company reported ($0.33) earnings per share (EPS) for the quarter. Ainos had a negative trailing twelve-month return on equity of 75.16% and a negative net margin of 15,348.14%.

Ainos shares reverse split on the morning of Thursday, December 14th 2023. The 1-5 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Ainos (AIMD) raised $3 million in an initial public offering on Tuesday, August 9th 2022. The company issued 800,000 shares at $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ainos investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Last Earnings
11/06/2024
Today
11/24/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/14/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AIMD
Previous Symbol
NASDAQ:AIMD
Employees
46
Year Founded
N/A

Profitability

Net Income
$-13,770,000.00
Net Margins
-15,348.14%
Pretax Margin
-39,441.14%

Debt

Sales & Book Value

Annual Sales
$120,000.00
Book Value
$1.30 per share

Miscellaneous

Free Float
12,401,000
Market Cap
$6.45 million
Optionable
Not Optionable
Beta
1.40
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:AIMD) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners